What treatment is recommended for stage C patients with heart failure and preserved ejection fraction (HFpEF)?

Stage C patients with heart failure and preserved ejection fraction (HFpEF) often present with a combination of heart failure symptoms and coexisting conditions such as hypertension. Management of these patients primarily focuses on controlling related conditions, particularly hypertension, to alleviate heart failure symptoms and improve quality of life.

Following published antihypertensive therapy guidelines is crucial because managing hypertension can reduce cardiac workload and help prevent disease progression. Medications such as ACE inhibitors, ARBs, and diuretics may be utilized as part of a comprehensive treatment strategy tailored to the individual patient's clinical scenario, thereby improving outcomes in this population.

Reliance solely on diuretics may help with fluid retention but does not address the root causes contributing to heart failure in HFpEF. The use of antibiotics is not indicated unless there is a specific infectious process. Immediate heart surgery is typically reserved for patients with specific structural heart problems or acute conditions, making it unsuitable for the general management of HFpEF. Therefore, the recommended approach is to adhere to established antihypertensive guidelines, which ultimately aligns with current best practices in managing HFpEF in stage C patients.